Published in Am J Cardiol on October 01, 1977
Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation. West J Med (1989) 1.42
Watching, but not waiting: vascular neurology perspective on the disparate regulatory pathways for stroke. J Neurointerv Surg (2014) 1.39
The drug treatment of atrial fibrillation. Br J Clin Pharmacol (1991) 1.01
The role of echocardiography in the investigation of focal cerebral ischaemia. Postgrad Med J (1984) 0.98
Stroke propensity is increased under atrial fibrillation hemodynamics: a simulation study. PLoS One (2013) 0.80
Mechanical valve dysfunction in yemen. Heart Views (2010) 0.80
Athlete's bradycardia as an embolising disorder? Symptomatic arrhythmias in patients aged less than 50 years. Br Heart J (1984) 0.78
Neurologic complications of cardiovascular diseases. J Natl Med Assoc (1989) 0.75
Treatment of nonvalvular atrial fibrillation. West J Med (1995) 0.75
Atrial Fibrillation: Biophysics, Molecular Mechanisms, and Novel Therapies. Biomed Res Int (2015) 0.75
Thrombosis: its role and prevention in cardiovascular events-Part II. West J Med (1981) 0.75
Atrial fibrillation and embolism. Can Med Assoc J (1983) 0.75
A study on cerebral embolism in mitral stenosis. Korean J Intern Med (1986) 0.75
Role of Aortic Geometry on Stroke Propensity based on Simulations of Patient-Specific Models. Sci Rep (2017) 0.75
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery (1980) 5.59
Lacunar strokes and infarcts: a review. Neurology (1982) 5.39
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
The incidence of deep venous thrombosis after laparoscopic cholecystectomy. Med J Aust (1996) 3.63
Restrictive cardiomyopathy. N Engl J Med (1997) 3.29
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
The arterial lesions underlying lacunes. Acta Neuropathol (1968) 3.06
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82
Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol (1989) 2.81
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation (2001) 2.71
Specific Tissue Reaction to Phospholipids: A Suggested Explanation for the Similarity of the Lesions of Silicosis and Pulmonary Tubercolosis. Can Med Assoc J (1937) 2.67
Reversible cerebral segmental vasoconstriction. Stroke (1988) 2.63
Some neuro-ophthalmological observations. J Neurol Neurosurg Psychiatry (1967) 2.39
Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol (1971) 2.35
Basilar artery branch occlusion: a cause of pontine infarction. Neurology (1971) 2.31
Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol (1992) 2.30
Capsular infarcts: the underlying vascular lesions. Arch Neurol (1979) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet (2001) 2.13
The Cellular Reaction to Silica. Can Med Assoc J (1935) 2.11
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell (1986) 1.98
Combined endovascular and open surgery for four-vessel cerebrovascular occlusive disease. J Endovasc Ther (2001) 1.98
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Ataxic hemiparesis. A pathologic study. Arch Neurol (1978) 1.92
Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology (2002) 1.92
Transient global amnesia. Precipitating activities and other observations. Arch Neurol (1982) 1.92
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg (2001) 1.77
Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci (1980) 1.76
Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation (1999) 1.74
Hydrocephalus as a cause of disturbances of gait in the elderly. Neurology (1982) 1.73
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation (2000) 1.70
An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69
Morphology after transluminal angioplasty in human beings. N Engl J Med (1981) 1.69
Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation (1995) 1.68
Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management. Circulation (1979) 1.67
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost (2003) 1.64
Acute cerebellar infarction in the PICA territory. Arch Neurol (1975) 1.64
Potential hazards and artifacts of ferromagnetic and nonferromagnetic surgical and dental materials and devices in nuclear magnetic resonance imaging. Radiology (1983) 1.62
Ruptured abdominal aortic aneurysms: who should be offered surgery? J Vasc Surg (1996) 1.60
Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke (2003) 1.60
Further experience with the syndrome of "normal" pressure hydrocephalus. J Neurosurg (1969) 1.59
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
Carotid Doppler ultrasound criteria for internal carotid artery stenosis based on residual lumen diameter calculated from en bloc carotid endarterectomy specimens. Stroke (1996) 1.58
Release of active tissue factor by human arterial smooth muscle cells. Circ Res (2000) 1.57
Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol (1990) 1.55
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol (1990) 1.51
The human thalamocortical sensory path in the internal capsule: evidence from a small capsular hemorrhage causing a pure sensory stroke. Ann Neurol (1977) 1.51
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport (1999) 1.49
The nature of posttraumatic epilepsy. J Neurosurg (1979) 1.46
Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations. Neurosurgery (1978) 1.45
Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation (1982) 1.44
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation (1991) 1.44
Thalamic pure sensory stroke: a pathologic study. Neurology (1978) 1.43
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology (2004) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
"Borderline" myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol (1990) 1.39
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
The risk of embolic stroke. Another piece of the puzzle. N Engl J Med (1994) 1.36
Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med (1999) 1.36
The clinical picture in occult hydrocephalus. Clin Neurosurg (1977) 1.35
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation (1989) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation (1981) 1.34
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol (1999) 1.33
A lacunar stroke. The dysarthria-clumsy hand syndrome. Neurology (1967) 1.33
Spontaneous dissection of cervico-cerebral arteries. Can J Neurol Sci (1978) 1.32
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem (1997) 1.29
Collagen fibril bundles: a branching assembly unit in tendon morphogenesis. Development (1989) 1.28
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury. Circulation (2001) 1.27
In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest (1996) 1.26
Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry (1977) 1.26
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation (1988) 1.25
The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology (1993) 1.24
Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg (1993) 1.22
Principles of nuclear magnetic resonance imaging. Radiology (1982) 1.21
NMR imaging of intracranial hemorrhage. J Comput Assist Tomogr (1984) 1.20
Disorientation for place. Arch Neurol (1982) 1.20
The neurological examination of the comatose patient. Acta Neurol Scand (1969) 1.19
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation (1996) 1.18
Identification of active tissue factor in human coronary atheroma. Circulation (1996) 1.18
Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost (1997) 1.18
Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol (1997) 1.18
Pure sensory stroke and allied conditions. Stroke (1982) 1.15
Late-life migraine accompaniments--further experience. Stroke (1986) 1.15
Venous endothelium of experimental arteriovenous fistulas in rabbits. Circ Res (1972) 1.15
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest (1988) 1.14